Sign In
Buy COR
$306.28
-2.09 (-0.678%)
At Close: Aug 04, 2026
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 4.625% Senior Notes due December 15, 2027 (the “2027 Notes
Here's Why Cencora (COR) is a Strong Momentum Stock
03:25pm, Monday, 02'nd Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Camino Announces a Private Placement of up to CAD$2.0 Million
08:30am, Thursday, 28'th Nov 2024
VANCOUVER, BC / ACCESSWIRE / November 28, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce that, further to its news release dated Octob
Cencora to Host Inaugural Product Showcase
08:30am, Tuesday, 26'th Nov 2024
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, will host its inaugural Product Showcase, an event that will provide increased visibility into the company's portfolio of solu
Why Cencora (COR) is a Top Value Stock for the Long-Term
10:45am, Monday, 25'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Scoop up These 3 GARP Stocks to Receive Handsome Returns
09:55am, Monday, 25'th Nov 2024
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. COR, RJF and CTAS are some stocks that hold promise.
Cencora Rallies 19.7% Year to Date: What's Driving the Stock?
10:16am, Friday, 22'nd Nov 2024
COR is gaining traction from the robust U.S. Healthcare Solutions segment, which raises optimism about the stock.
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
10:45am, Tuesday, 19'th Nov 2024
Here is how Cencora (COR) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Here's Why Cencora (COR) is a Strong Growth Stock
10:45am, Wednesday, 13'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
10:15am, Wednesday, 13'th Nov 2024
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Cencora (COR) is a Top Momentum Stock for the Long-Term
10:55am, Monday, 11'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cencora Q4 Earnings & Revenues Beat Estimates, Margins Decline Y/Y
12:25pm, Wednesday, 06'th Nov 2024
COR's fourth-quarter fiscal 2024 results showcase a strong segmental performance.
Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings
11:38am, Wednesday, 06'th Nov 2024
On Wednesday, Cencora, Inc.'s COR fourth-quarter 2024 sales increased 14.7% to $79.1 billion, beating the consensus of $77.65 billion.
Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript
10:56am, Wednesday, 06'th Nov 2024
Cencora, Inc. (NYSE:COR ) Q4 2024 Earnings Call Transcript November 6, 2024 8:30 AM ET Company Participants Bennett Murphy - SVP, Head of IR Bob Mauch - President and CEO Laz Krikorian - SVP and CAO C
Here's Why Cencora (COR) is a Strong Value Stock
10:45am, Wednesday, 06'th Nov 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
